Synaptive Medical Announces Close of $25M Preferred Share Financing

Synaptive_logo_RGB_black.jpg

Synaptive Medical, a Toronto-based medical and technology company solving surgical, imaging and data challenges, has completed a first round of new preferred equity investment totaling $25,000,000 USD. The investment was led by Linamar Corporation and Audible Capital Corporation.

Previous
Previous

ProteinQure named one of CB Insights' Game Changers for 2020

Next
Next

Flosonics Medical Counts Down to Product Launch in Early 2020